The authors wish to make the following corrections to this paper [1]:
The version of Figure 3a that was uploaded with the manuscript was based on a calculation error, whereas the publication text referred to the correct version of Figure 3a. After the publication of this work, we noted the mistake and issued an erratum on the y-axis. Figure 3a has now been corrected in this erratum.
Figure 3.
(a) Transendothelial electrical resistance (TEER, expressed as Ω × cm2) and (b) endothelial Pe for sodium fluorescein (NaFl) and FITC-dextran (Pe, expressed in cm/s) of the blood–brain barrier models built from mouse primary brain endothelial cells (BMEC, blue) and from mouse brain endothelial cell line (bEnd.3, red) at day 7. All data are presented as means ± SD (n = 12 for TEER, n = 4 for Pe). Statistical analysis: unpaired t test with Welch’s correction (ns: p ≥ 0.0332, **** p < 0.0001, ND- not detected).
The authors would like to apologize for any inconvenience caused to the readers by these changes.
References
- Puscas, I.; Bernard-Patrzynski, F.; Jutras, M.; Lécuyer, M.-A.; Bourbonnière, L.; Prat, A.; Leclair, G.; Roullin, V.G. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).